Analyze Diet

Effects of polysulfated glycosaminoglycan on chemical and physical defects in equine articular cartilage.

Abstract: The effect of intra-articular polysulfated glycosaminoglycan (PSG) on repair of chemical and physical articular cartilage injuries was evaluated in 8 horses. In each horse, a partial- and a full-thickness articular cartilage defect was made on the distal articular surface of the radial carpal bone. In the contralateral middle carpal joint, a chemical articular cartilage injury was induced by injecting 50 mg of Na monoiodoacetate (MIA). Four of the 8 horses were not treated (controls), and 4 horses were treated by intra-articular injection of 250 mg of PSG into both middle carpal joints once a week for 5 treatments starting 1 week after cartilage injury. Horses were maintained for 8 weeks. There was less joint circumference enlargement in PSG-treated horses in MIA-injected and physical defect carpi, compared with that in controls. In MIA-injected joints, there was less articular cartilage fibrillation and erosion, less chondrocyte death, and greater safranin-O staining for glycosaminoglycans in PSG-treated horses. Evaluation of joints in which physical defects were made revealed no differences between control and PSG-injected joints. None of the partial-thickness defects had healed. Full-thickness defects were repaired with fibrous tissue (which was more vascular and cellular in PSG-injected joints) and occasionally small amounts of fibrocartilage. Seemingly, PSG had chondroprotective properties in a model of chemically induced articular cartilage damage, whereas PSG had no obvious effect in a physical articular cartilage-defect model.
Publication Date: 1987-09-01 PubMed ID: 3662210
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates how using polysulfated glycosaminoglycan (PSG), injected directly into the joint, can affect the repair of chemically and physically damaged horse articular cartilage. The study found that PSG exhibits protective properties for the cartilage in the case of chemically induced damage but didn’t show much difference when applied to physical cartilage defects.

Research Methodology

  • The researchers used eight horses for the study. Each horse was subjected to both a partial- and full-thickness physical defect on the distal articular surface of the radial carpal bone. Furthermore, a chemical articular cartilage injury was induced in the contralateral middle carpal joint by injecting 50 mg of Na monoiodoacetate (MIA).
  • Four of the eight horses were left untreated as controls, while the remaining four were treated with an intra-articular injection of 250 mg of PSG into both middle carpal joints weekly for five weeks, starting one week after the cartilage injury.
  • The horses were observed for eight weeks.

Results and Observations

  • The researchers found less joint circumference enlargement in PSG-treated horses compared to the controls for both the chemically induced and physical defect cases.
  • In terms of chemically induced cases, PSG-treated horses showed less articular cartilage fibrillation and erosion, reduced chondrocyte death, and greater safranin-O staining (indicating more glycosaminoglycans, important compounds for cartilage function and structure).
  • Where physical defects were concerned, no significant differences between control and PSG-treated joints were observed. None of the partial-thickness defects had healed, although full-thickness defects were repaired with fibrous tissue and occasionally small amounts of fibrocartilage.
  • A note was made that the fibrous tissue was more vascular and cellular in PSG-injected joints.

Conclusion

  • The study results concluded that the tested substance, polysulfated glycosaminoglycan (PSG), demonstrated chondroprotective abilities in the case of chemically induced joint damage.
  • However, on the other hand, it didn’t exhibit any considerable effect on physically induced cartilage defects. Therefore, the utility of PSG may be conditional depending on the nature of the cartilage injury.

Cite This Article

APA
Yovich JV, Trotter GW, McIlwraith CW, Norrdin RW. (1987). Effects of polysulfated glycosaminoglycan on chemical and physical defects in equine articular cartilage. Am J Vet Res, 48(9), 1407-1414.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 48
Issue: 9
Pages: 1407-1414

Researcher Affiliations

Yovich, J V
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523.
Trotter, G W
    McIlwraith, C W
      Norrdin, R W

        MeSH Terms

        • Animals
        • Carpus, Animal / injuries
        • Carpus, Animal / pathology
        • Cartilage Diseases / drug therapy
        • Cartilage Diseases / pathology
        • Cartilage Diseases / veterinary
        • Cartilage, Articular / injuries
        • Cartilage, Articular / pathology
        • Forelimb / injuries
        • Glycosaminoglycans / therapeutic use
        • Horse Diseases / drug therapy
        • Horse Diseases / pathology
        • Horses
        • Lameness, Animal / drug therapy

        Citations

        This article has been cited 3 times.
        1. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012 Nov;1(11):297-309.
          doi: 10.1302/2046-3758.111.2000132pubmed: 23610661google scholar: lookup
        2. Trotter GW, Yovich JV, McIlwraith CW, Norrdin RW. Effects of intramuscular polysulfated glycosaminoglycan on chemical and physical defects in equine articular cartilage. Can J Vet Res 1989 Apr;53(2):224-30.
          pubmed: 2469533
        3. White GW. Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data. Open Vet J 2025 Sep;15(9):4007-4023.
          doi: 10.5455/OVJ.2025.v15.i9.6pubmed: 41200294google scholar: lookup